Kevin D. Freeman - Director at Galectin Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
GALT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kevin D. Freeman - trading volume in the past year for Galectin Therapeutics Inc

Holdings reported by Kevin D. Freeman for Galectin Therapeutics Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 80K $111K $1.39 Jul 17, 2025 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC
Common Stock 49.8K $69.2K $1.39 Jul 17, 2025 Direct
Common Stock 18.1K $25.1K $1.39 Jul 17, 2025 IRA
Stock Option (right to buy) 60K Jan 23, 2025 Direct Common Stock

Transactions reported by Kevin D. Freeman for Galectin Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.